SCM
Soleus Capital Management Portfolio holdings
AUM
$1.45B
1-Year Return
18.23%
This Quarter Return
+7.62%
1 Year Return
+18.23%
3 Year Return
+274.85%
5 Year Return
+440.77%
10 Year Return
–
AUM
$993M
AUM Growth
+$93.1M
(+10%)
Cap. Flow
+$136M
Cap. Flow
% of AUM
13.75%
Top 10 Holdings %
Top 10 Hldgs %
39.81%
Holding
126
New
24
Increased
29
Reduced
26
Closed
35
Top Buys
| 1 |
GSK
GSK
|
$34.2M |
| 2 |
Treace Medical Concepts
TMCI
|
$25M |
| 3 |
TG Therapeutics
TGTX
|
$20.5M |
| 4 |
Insulet
PODD
|
$20.4M |
| 5 |
Teva Pharmaceuticals
TEVA
|
$18.4M |
Top Sells
| 1 |
Charles River Laboratories
CRL
|
$22.2M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$13.7M |
| 3 |
Arcellx
ACLX
|
$12.9M |
| 4 |
CVS Health
CVS
|
$11.3M |
| 5 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$9.95M |
Sector Composition
| 1 | Healthcare | 98.3% |
| 2 | Consumer Staples | 1.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
AngioDynamics
ANGO
$437M
| – | – |
-768,500
| Closed | -$8.02M |
|